Reference health

Keyhole Limpet Hemocyanin-Conjugated Peptides from Hepatitis C Virus Glycoproteins Elicit Neutralizing Antibodies in BALB/c Mice

https://doi.org/10.1155/2021/3108157
CiteStamped reference-health badge
51/51 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

1 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 51 checked references that resolve
resolves10.1515/jtim-2017-0007
Direct acting anti-hepatitis C virus drugs: Clinical pharmacology and future direction
resolves10.1038/nm.3183
Current progress in development of hepatitis C virus vaccines
resolves10.1053/j.gastro.2016.04.003
Hepatitis C Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free Regimens
resolves10.1038/s41598-017-15987-1
Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs
resolves10.1038/srep20310
Global prevalence of pre-existing HCV variants resistant to direct-acting antiviral agents (DAAs): mining the GenBank HCV genome data
resolves10.1038/emi.2013.79
Progress towards a hepatitis C virus vaccine
resolves10.3389/fmicb.2014.00329
Challenges to the development of vaccines to hepatitis C virus that elicit neutralizing antibodies
resolves10.1371/journal.pone.0023699
A Weak Neutralizing Antibody Response to Hepatitis C Virus Envelope Glycoprotein Enhances Virus Infection
resolves10.1073/pnas.0902749106
Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity
resolves10.1128/JVI.02458-15
Antibody Response to Hypervariable Region 1 Interferes with Broadly Neutralizing Antibodies to Hepatitis C Virus
resolves10.1136/gutjnl-2017-314870
A trivalent HCV vaccine elicits broad and synergistic polyclonal antibody response in mice and rhesus monkey
resolves10.1093/infdis/jir423
Clearance of Genotype 1b Hepatitis C Virus in Chimpanzees in the Presence of Vaccine-Induced E1-Neutralizing Antibodies
resolves10.1126/scitranslmed.3009185
A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory
resolves10.1006/viro.1996.0497
A Hyperimmune Serum against a Synthetic Peptide Corresponding to the Hypervariable Region 1 of Hepatitis C Virus Can Prevent Viral Infection in Cell Cultures
resolves10.3748/wjg.v12.i16.2530
Antibody to E1 peptide of hepatitis C virus genotype 4 inhibits virus binding and entry to HepG2 cells in vitro
resolves10.1186/1743-422X-6-66
Conserved peptides within the E2 region of Hepatitis C virus induce humoral and cellular responses in goats
resolves10.1126/science.1114016
Complete Replication of Hepatitis C Virus in Cell Culture
resolves10.1038/nm1268
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
resolves10.1371/journal.pone.0138756
Antibodies Targeting Novel Neutralizing Epitopes of Hepatitis C Virus Glycoprotein Preclude Genotype 2 Virus Infection
resolves10.1371/journal.pone.0066872
Determination of the Human Antibody Response to the Neutralization Epitopes Encompassing Amino Acids 313–327 and 432–443 of Hepatitis C Virus E1E2 Glycoproteins
resolves10.1073/pnas.1218260109
Highly efficient full-length hepatitis C virus genotype 1 (strain TN) infectious culture system
resolves10.1073/pnas.1016606108
MicroRNA-122 antagonism against hepatitis C virus genotypes 1–6 and reduced efficacy by host RNA insertion or mutations in the HCV 5′ UTR
resolves10.1053/j.gastro.2013.11.009
Differential Sensitivity of 5′UTR-NS5A Recombinants of Hepatitis C Virus Genotypes 1−6 to Protease and NS5A Inhibitors
resolves10.1371/journal.ppat.0040017
The Mannose Receptor Mediates Dengue Virus Infection of Macrophages
resolves10.1371/journal.pone.0135963
Real-Time PCR Assays for the Quantification of HCV RNA: Concordance, Discrepancies and Implications for Response Guided Therapy
resolves10.1016/j.chom.2018.10.012
Broadly Neutralizing Antibody Mediated Clearance of Human Hepatitis C Virus Infection
resolves10.1073/pnas.1114927109
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
resolves10.1073/pnas.91.4.1294
Vaccination of chimpanzees against infection by thehepatitis C virus.
resolves10.1093/infdis/jir511
Vaccine-Induced Cross-Genotype Reactive Neutralizing Antibodies Against Hepatitis C Virus
resolves10.1128/JVI.01462-16
Altered Glycosylation Patterns Increase Immunogenicity of a Subunit Hepatitis C Virus Vaccine, Inducing Neutralizing Antibodies Which Confer Protection in Mice
resolves10.1128/JVI.01138-09
Identification and Characterization of Broadly Neutralizing Human Monoclonal Antibodies Directed against the E2 Envelope Glycoprotein of Hepatitis C Virus
resolves10.1186/s12879-019-4571-5
A multiepitope peptide vaccine against HCV stimulates neutralizing humoral and persistent cellular responses in mice
resolves10.1186/1743-422X-8-391
Neutralizing activities of caprine antibodies towards conserved regions of the HCV envelope glycoprotein E2
resolves10.1111/j.1365-2249.1995.tb08351.x
Human monoclonal antibodies for the immunological characterization of a highly conserved protein domain of the hepatitis C virus glycoprotein E1
resolves10.1128/JVI.68.7.4420-4426.1994
Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus
resolves10.1128/JVI.01402-14
Identification of Conserved Residues in Hepatitis C Virus Envelope Glycoprotein E2 That Modulate Virus Dependence on CD81 and SRB1 Entry Factors
resolves10.3390/vaccines8020294
Specific Antibodies Induced by Immunization with Hepatitis B Virus-Like Particles Carrying Hepatitis C Virus Envelope Glycoprotein 2 Epitopes Show Differential Neutralization Efficiency
resolves10.1002/hep.510250530
Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus
resolves10.1006/viro.1995.1196
Antibodies in Human Sera Specific to Hypervariable Region 1 of Hepatitis C Virus Can Block Viral Attachment
resolves10.1073/pnas.93.26.15394
Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein
resolves10.1136/gutjnl-2015-310300
HVR1-mediated antibody evasion of highly infectious in vivo adapted HCV in humanised mice
resolves10.1128/JVI.02141-17
Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine
resolves10.1038/srep00267
Hepatitis C Virus Antigenic Convergence
resolves10.3389/fimmu.2018.02146
Hypervariable Region 1 in Envelope Protein 2 of Hepatitis C Virus: A Linchpin in Neutralizing Antibody Evasion and Viral Entry
resolves10.1099/0022-1317-82-8-1877
Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2
resolves10.1074/jbc.M305289200
Cell Entry of Hepatitis C Virus Requires a Set of Co-receptors That Include the CD81 Tetraspanin and the SR-B1 Scavenger Receptor
resolves10.1053/jhep.2001.22175
Mimotopes of the hepatitis C virus hypervariable region 1, but not the natural sequences, induce cross-reactive antibody response by genetic immunization
resolves10.1186/s12985-020-01408-9
Role of HVR1 sequence similarity in the cross-genotypic neutralization of HCV
resolves10.1099/vir.0.028092-0
Characterization of antibody-mediated neutralization directed against the hypervariable region 1 of hepatitis C virus E2 glycoprotein
resolves10.3389/fimmu.2018.01480
Hepatitis C Vaccines, Antibodies, and T Cells
resolves10.1053/j.gastro.2018.08.060
Approaches, Progress, and Challenges to Hepatitis C Vaccine Development
The 1 reference without a DOI — listed, not checked
no DOI — not checkedGlobal hepatitis report
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1155/2021/3108157"><img src="https://citestamp.com/citestamped/10.1155/2021/3108157/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1155/2021/3108157/badge.svg)](https://citestamp.com/citestamped/10.1155/2021/3108157)